Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Sedation Methods in PTBD: How Two Regimens Compare for Quality and Recovery

Official title: Evaluation of Sedation Methods Used in Percutaneous Transhepatic Biliary Drainage Procedures in Terms of Procedure Quality, Recovery Time, and Side Effects

Run by Ankara City Hospital Bilkent · NCT07640243 · Data updated 2026-11-12

This study tests two sedation plans (propofol with remifentanil vs propofol with ketamine) to see which helps patients recover faster after PTBD while staying comfortable and safe.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment98 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, Ankara)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedMay 30, 2026
Study endsJune 10, 2026
Registry record updatedJune 10, 2026
Trial IDNCT07640243 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for elective PTBD or biliary stenting with ASA II–IV, able to consent, and without contraindications to propofol, remifentanil, or ketamine.

Probably not a fit

Patients with contraindications to study drugs, emergency procedures, or significant valve disease or heart failure may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-center trial compares two commonly used sedation regimens during percutaneous transhepatic biliary drainage in adults with biliary obstruction and comorbidities. Participants are assigned to propofol–remifentanil or propofol–ketamine with target Ramsay 3–4, and monitored for recovery time, pain, satisfaction, and safety. The study uses standard monitoring and evaluates hemodynamics, pain scores, and adverse events to determine which approach offers better recovery and procedural quality in frail and elderly patients. Primary Outcome: recovery time via the Modified Aldrete Score. Secondary outcomes include procedure quality, patient and operator satisfaction, and incidence of sedation-related events. The trial aims to define an optimal sedation strategy for high-risk PTBD patients.

Why it matters

Potential benefit: If successful, the trial could identify a sedation regimen that enables faster recovery and fewer complications for frail patients undergoing PTBD.

How similar studies have gone: Previous studies have explored sedation strategies in interventional radiology, with mixed results; this trial tests two commonly used regimens in a frail, elderly population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for elective percutaneous transhepatic biliary drainage (PTBD) and/or biliary stenting
* ASA physical status II-IV
* Fasting time of at least 6 hours prior to the procedure
* Ability to provide written informed consent

Exclusion Criteria:

* Inability to provide informed consent or to complete study assessments (e.g., Ramsay Sedation Scale, FRAIL scale, Numeric Rating Scale)
* Clinical diagnosis of Alzheimer's Disease
* Clinical diagnosis of demantia
* Known allergy or hypersensitivity to propofol, remifentanil, ketamine, ondansetron, or deksketoprofen
* Grade 3-4 aortic, mitral, or tricuspid valve disease
* Advanced or decompensated heart failure (ejection fraction \<25%)
* Emergency procedures
* Refusal to participate in the study

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.